Barclays kept its 'Hold' rating on Bausch Health and raised the price target to $9.

Nov 11, 2026, 7:38 AM ETOpinionRead the original at moomoo.com

Neutral

Barclays raised its Bausch Health price target to $9 but kept its Hold rating. The higher target is more hopeful, but the unchanged rating and lack of new company results leave the outlook unchanged.

BHC · Bausch Health Companies Inc.

AI read · Neutral

The AI's read

The bank's higher target gives a more hopeful view of Bausch Health's shares. Keeping Hold shows it did not change its rating. The article reports no new company results or business changes, so it does not show a clear change in the company's outlook.

Get alerts for BHC

Follow Bausch Health Companies Inc. (BHC) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BHC

Free on the App Store and Google Play, or on the web.